EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pro-Adrenomedullin Associates with Congestion in Acute Heart Failure Patients

Benedikt N Beer iD, Saman Keshtkaran, Caroline Kellner, Lisa Besch, Jonas Sundermeyer, Angela Dettling, Paulus Kirchhof, Stefan Blankenberg, Christina Magnussen, Benedikt Schrage

ESC Heart Failure · 01.12.2024 · 11 (6) · 3598-3606

DOI: 10.1002/ehf2.15007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 20.08.2024. Verfasst von Benedikt N Beer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Adrenomedullin, Biomarkers, Heart Failure. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University Medical Center Hamburg-Eppendorf, Universitätsklinikum Hamburg-Eppendorf.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Congestion is a major determinant of outcomes in acute heart failure. Its assessment is complex, making sufficient decongestive therapy a challenge. Residual congestion is frequent at discharge, increasing the risk of re-hospitalization and death. Mid-regional pro-adrenomedullin mirrors vascular integrity and may therefore be an objective marker to quantify congestion and to guide decongestive therapies in patients with acute heart failure. Methods and results Observational, prospective, single-centre study in unselected patients presenting with acute heart failure. This study aimed to assess adrenomedullin's association with congestion and clinical outcomes: in-hospital death, post-discharge mortality and in-hospital worsening heart failure according to RELAX-AHF-2 trial criteria. Pro-adrenomedullin was quantified at baseline and at discharge. Congestion was assessed applying clinical scores. Cox and logistic regression models with adjustment for clinical features were fitted. N = 233, median age 77 years (IQR 67, 83), 148 male (63.5%). Median pro-adrenomedullin 2.0 nmol/L (IQR 1.4, 2.9). Eight patients (3.5%) died in hospital and 100 (44.1%) experienced in-hospital worsening heart failure. After discharge, 60 patients (36.6%) died over a median follow-up of 1.92 years (95% CI: 1.76, 2.46). Pro-adrenomedullin concentrations (logarithmized) were significantly associated with congestion, both at enrolment (β = 0.36 and 0.81 depending on score, each P < 0.05) and at discharge (β = 1.12, P < 0.001). Enrolment of pro-adrenomedullin was associated with in-hospital worsening heart failure [OR 4.23 (95% CI: 1.87, 9.58), P < 0.001], and pro-adrenomedullin at discharge was associated with post-discharge death [HR 3.93 (1.86, 8.67), P < 0.001].

Conclusion

Elevated pro-adrenomedullin is associated with in-hospital worsening heart failure and with death during follow-up in patients with acute heart failure. Further research is needed to validate this finding and to explore the ability of pro-adrenomedullin to guide decongestive treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdrenomedullinBiomarkersHeart FailureAgedAged, 80 and overFemaleHumansMaleAcute DiseaseFollow-Up StudiesHospital MortalityPrognosisProspective StudiesSurvival RateProtein Precursors

Stichwörter der Autor:innen

Acute heart failureAdrenomedullinBiomarkerCongestionPro‐ADMTherapy guidance

Substanzen

AdrenomedullinBiomarkersproadrenomedullinProtein Precursors

Autor:innen und Institutionen

  • Department of Cardiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany.
  • Center for Population Health Innovation (POINT), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.

ORCID-Profile: Benedikt N Beer

Förderung

  • University Medical Center Hamburg-Eppendorf
  • Universitätsklinikum Hamburg-Eppendorf

Zitieren

APA

Beer, B. N., Keshtkaran, S., Kellner, C., Besch, L., Sundermeyer, J., Dettling, A., Kirchhof, P., Blankenberg, S., Magnussen, C., & Schrage, B. (2024). Pro-Adrenomedullin Associates with Congestion in Acute Heart Failure Patients. ESC Heart Failure, 11(6), 3598-3606. https://doi.org/10.1002/ehf2.15007

Vancouver

Beer BN, Keshtkaran S, Kellner C, Besch L, Sundermeyer J, Dettling A, et al. Pro-Adrenomedullin Associates with Congestion in Acute Heart Failure Patients. ESC Heart Failure. 2024;11(6):3598-3606. doi:10.1002/ehf2.15007

BibTeX
@article{Beer2024,
  author = {Beer, Benedikt N and Keshtkaran, Saman and Kellner, Caroline and Besch, Lisa and Sundermeyer, Jonas and Dettling, Angela and Kirchhof, Paulus and Blankenberg, Stefan and Magnussen, Christina and Schrage, Benedikt},
  title = {Pro-Adrenomedullin Associates with Congestion in Acute Heart Failure Patients},
  journal = {ESC Heart Failure},
  year = {2024},
  volume = {11},
  number = {6},
  pages = {3598--3606},
  doi = {10.1002/ehf2.15007}
}
Kostenlos starten →